Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionWalleye Trading LLC
Latest Disclosed Ownership81 shares
Latest Disclosed Value $ 42,401
Walleye Trading LLC ownership in YDO1 / Madrigal Pharmaceuticals, Inc.

On May 8, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 81 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $36,474 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 214 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -62.15% during the quarter. The current value of the position is $34,522 USD.

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (YDO1) in the form of stock options. The firm currently holds call options representing 400 of underlying shares valued at $209,388 USD and put options representing 100 of underlying shares valued at $52,347 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:YDO1 / Madrigal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 81 -133 -62.15 42 -66.13 0.0001
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 214 214 125 0.0002
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -3,936 -100.00 0 -100.00
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,936 3,936 256 0.0008
2022-08-08 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -1,601 -100.00 0 -100.00
2022-05-16 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,601 -919 -36.47 157 -26.64 0.0005
2022-02-14 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,520 2,520 214 0.0007
2021-02-16 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -1,600 -100.00 0 -100.00
2020-11-16 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,600 1,515 1,782.35 190 1,800.00 0.0010
2020-08-14 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 85 85 10 0.0001
2019-02-14 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -46 -100.00 0 -100.00
2018-11-14 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 46 46 10 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 400 209 n/a n/a n/a
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 700 321 n/a n/a n/a
2025-05-14 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 20,400 6,295 n/a n/a n/a
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 1,300 -90.51 347 -89.05 n/a n/a n/a
2024-02-14 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 13,700 -16.97 3,170 31.55 n/a n/a n/a
2023-11-21 2023-09-30 13F/A MADRIGAL PHARMACEUTICALS COM Call 16,500 26.92 2,410 -19.78 n/a n/a n/a
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 16,500 2,410 n/a n/a n/a
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 13,000 -5.11 3,003 -9.49 n/a n/a n/a
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 13,700 67.07 3,319 39.41 n/a n/a n/a
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 8,200 -45.33 2,380 144.10 n/a n/a n/a
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 15,000 78.57 975 62.23 n/a n/a n/a
2022-08-08 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 8,400 601 n/a n/a n/a
2021-02-16 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 7,200 -70.12 855 -68.67 n/a n/a n/a
2020-08-14 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 24,100 2,729 n/a n/a n/a
2020-05-15 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 5,400 492 n/a n/a n/a
2019-11-14 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 11,500 45.57 1,205 21.72 n/a n/a n/a
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 7,900 990 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 100 -80.00 52 -82.13 n/a n/a n/a
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 500 -72.22 291 -64.73 n/a n/a n/a
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 1,800 826 n/a n/a n/a
2025-05-14 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 1,700 525 n/a n/a n/a
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 800 -68.00 214 -63.15 n/a n/a n/a
2024-02-14 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 2,500 316.67 578 564.37 n/a n/a n/a
2023-11-21 2023-09-30 13F/A MADRIGAL PHARMACEUTICALS COM Put 600 20.00 88 -24.35 n/a n/a n/a
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 600 88 n/a n/a n/a
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 500 66.67 116 59.72 n/a n/a n/a
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 300 -95.08 73 -95.93 n/a n/a n/a
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 6,100 -93.25 1,771 -69.87 n/a n/a n/a
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 90,400 1,058.97 5,875 952.87 n/a n/a n/a
2022-08-08 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 7,800 1,014.29 558 708.70 n/a n/a n/a
2022-05-16 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 700 69 n/a n/a n/a
2021-02-16 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 16,700 475.86 1,983 504.57 n/a n/a n/a
2020-08-14 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 2,900 328 n/a n/a n/a
2020-05-15 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 2,500 228 n/a n/a n/a
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 2,000 251 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.